Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-11-28
2006-11-28
Coleman, Brenda (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S022000, C546S269100, C546S269700, C546S270400, C548S112000, C548S130000, C548S132000, C548S181000, C548S183000, C548S202000, C548S203000, C548S204000, C548S205000
Reexamination Certificate
active
07141672
ABSTRACT:
This invention provides compounds of Formula I having the structureor a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
REFERENCES:
patent: 3666473 (1972-05-01), Colom et al.
patent: 4117151 (1978-09-01), Deschamps et al.
patent: 4153703 (1979-05-01), Harrison et al.
patent: 4808599 (1989-02-01), Dubroeucq et al.
patent: 5235064 (1993-08-01), Gapinski
patent: 5334598 (1994-08-01), Bagley et al.
patent: 5523302 (1996-06-01), Cain et al.
patent: 5596106 (1997-01-01), Cullinan et al.
patent: 5688821 (1997-11-01), Kees
patent: 5698574 (1997-12-01), Riedl et al.
patent: 6232322 (2001-05-01), Malamas
patent: 6391897 (2002-05-01), Malamas
patent: 6699896 (2004-03-01), Malamas
patent: 1249869 (1967-09-01), None
patent: 1291197 (1969-03-01), None
patent: 2616414 (1977-10-01), None
patent: 3110460 (1982-12-01), None
patent: 3342624 (1984-03-01), None
patent: 0092239 (1983-10-01), None
patent: 0276064 (1988-07-01), None
patent: 0382199 (1990-08-01), None
patent: 0568289 (1993-11-01), None
patent: 0629624 (1994-12-01), None
patent: 0693491 (1996-01-01), None
patent: 1293396 (1969-11-01), None
patent: 58150948 (1983-09-01), None
patent: 60172946 (1985-09-01), None
patent: 6236661 (1987-02-01), None
patent: 6236662 (1987-02-01), None
patent: 63161449 (1988-07-01), None
patent: 3247655 (1991-11-01), None
patent: 4016854 (1992-01-01), None
patent: 6348018 (1994-12-01), None
patent: 9111909 (1991-08-01), None
patent: 9422834 (1994-10-01), None
patent: 9422835 (1994-10-01), None
patent: 9608483 (1996-03-01), None
patent: 9609818 (1996-04-01), None
patent: 9634851 (1996-11-01), None
patent: 9721693 (1997-06-01), None
Ahmad, F. et al., Biochemica et Biophysica Acta, 1248, 1995, pp. 57-69.
Chang, A. Y. et al., Diabetes, 32, 1983, pp. 830-838.
Coleman, D. L., Diabetologia, 14, 1978, pp. 141-148.
DeFronzo, R. A. et al., Diabetes Care, 14:3, 1991, pp. 173-194.
Goldstein, B. J., Receptor, 3, 1993, pp. 1-15.
Goldstein, B. J. et al., Mol. and Cell. Biochem., 109, 1992, pp. 107-113.
Goldstein, B. J., J. Cell. Biochem., 48, 1992, pp. 33-42.
Haring, H. U., Diabetologia, 34, 1991, pp. 848-861.
Harris, M. I. et al., Diabetes in America, 1985, Chapter 29, pp. 1-48.
Jarrett, R. J., Diabetes/Metabolism Reviews, 5:7, 1989, pp. 547-558.
Lanzetta, P. A. et al., Analytical Biochem. 100, 1979, pp. 95-97.
McGuire, M. C. et al., Diabetes, 40, Jul. 1991, pp. 939-942.
Meyerovitch, J. et al., J. Clin. Invest., 87, Apr. 1991, pp. 1286-1294.
Meyerovitch, J. et al., J. Clin. Invest., 84, Sep. 1989, pp. 976-983.
Mitsunobu, O., Synthesis, Jan. 1981, pp. 1-28.
Nutaitis, C. F., Organic Preparations and Procedures Int., 23(4), 1991, pp.403- 411.
Perich, J. W. et al., Synthesis, Feb. 1988, pp. 142-144.
Phillion, D. P. et al., Tetrahedron, 27:13, 1986, pp. 1477-1480.
Pyorala, K. et al., Diabetes/Metabolism Reviews, 3:2, 1987, pp. 463-524.
Reaven, G. M. et al., Amer. J. Med., 60, 1976, pp. 80-88.
Sredy, J. et al., Metabolism, 44:8, 1995, pp. 1074-1081.
Stout, R. W. Metabolism, 34:12 (Suppl 1), Dec. 1985, pp. 7-12.
Zask, A. et al., J. Med. Chem., 33, 1990, pp. 1418-1423.
Chen, H.-M. et al., Indian J. Chem., 35B, Dec. 1996, pp. 1304-1307.
d'Ischia, M. et al., Tetrahedron, 43:2, 1987, pp. 431-434.
Dryhurst, G. et al., J. Am. Chem. Soc., 111, 1989, pp. 719-726.
Guirguis, N. R. et al., J. Parkt. Chemie, 332:3, 1990, pp. 414-418.
Guirguis, N. R. et al., Liebigs Ann. Chem., 1986, pp. 1003-1011.
Hashem, A. I., J. Prakt. Chemie, 319:4, 1977, pp. 689-692.
Konopelski, J.P. et al., Synlett, Letters, Jul. 1996, pp. 609-611.
Kuroda, T. et al., J. Org. Chem., 59, 1994, pp. 7353-7357.
Kuroda, T. et al., J. Chem. Soc., Chem. Commun., 1991, pp. 1635-1636.
Lefker, B. A. et al., Tetrahedron Letters, 35:29, 1994, pp. 5205-5208.
Molina, P. et al., Tetrahedron, 50:17, 1994, pp. 5027-5036.
Molina, P. et al., Tetrahedron Letters, 34:17, 1993, pp. 2809-2812.
Napolitano, A. et al., Tetrahedron, 45:21, 1989, pp. 6749-6760.
Schuster, I. I., et al., J. Org. Chem., 53, 1988, pp. 5819-5825.
Buu-Hoi, N. P. et al., J. Chem. Soc., 1957, pp. 625-628.
Brown, E. V. et al., J. Med. Chem., 14:1, 1971, pp. 84-85.
Kimura, T. et al., Tetrahedron Letters, 36:7, 1995, pp. 1079-1080.
Han, B. H. et al., Tetrahedron Letters, 31:8, 1990, pp. 1181-1182.
Kano, S. et al., Heterocycles, 19:6, 1982, pp. 1033-1037.
Martin, S.F. et al., J. Org. Chem., 49, 1984, pp. 2512-2513.
Eckert, T. et al., Arch. Pharm., 315, 1982, pp. 569-570.
Goldenberg, C. et al., Eur. J. Med. Chem., Chim. Ther., 12:1, Jan.-Feb. 1977, 81-86.
Artini, D. et al., Arzneim.-Forsch. (Drug Res.), 21:1, 1971, pp. 30-36.
Ayyangar, N.R. et al., Synthesis, Apr. 1991, pp. 322-324.
Darchen, A. et al., J.C.S. Chem. Comm., 1976, p. 820.
De Cointet, P. et al., Chimie Therapeutique, 5, Sep.-Oct. 1973, pp. 574-587.
Hamacher, H., Arch. Pharmaz., 308/75, pp. 290-301, 1975.
Massolini, G. et al., II Farmaco, 45(2), 1990, pp. 263-268.
Miyaura, N. et al., Synthetic Communications, 11:7, 1981, pp. 513-519.
Barraclough, P. et al., Arch. Pharm., 323, 1990, pp. 507-512.
Liebeskind, L. S. et al., J. Org. Chem., 55, 1990, pp. 5359-5364.
Toth, I., Liebigs Ann. Chem., 1994, pp. 685-688.
Katritsky, A.R. and Weeds, S.N., “The literature of heterocyclic chemistry”,Advances in Heterocyclic Chemistry, 7, 225, Academic Press, New York (1966).
Katritsky, A.R., “The literature of heterocyclic chemistry”,Advances in Heterocyclic Chemistry, 55, 31, Academic Press, New York (1992).
Miyaura et al., “Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounts”,Chem. Rev., 95:2457-2483 (1995).
Miyaura et al., “The Palladium-Catalyzed Cross-Coupling Reaction of Phenylboronic Acid with Haloarenes in the Presence of Bases”,Synthetic Communications, 11(7):513-519 (1981).
Thompson et al., “A General Synthesis of 5-Arylnicotinates”,J. Org. Chem., 49:5237-5243 (1984).
Coleman Brenda
Fish & Richardson P.C.
Wyeth
LandOfFree
Oxazole-aryl-carboxylic acids useful in the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxazole-aryl-carboxylic acids useful in the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxazole-aryl-carboxylic acids useful in the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3688267